SCHEMBL7781279

SCHEMBL7781279

OCc1cc(C(CO)NCCOc2ccc3c(c2)[nH]c2ccccc23)ccc1O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 4/20 0.39
ADRB2 P07550 10/20 0.38
NR1I2 O75469 1/20 0.37
CTSV O60911 1/20 0.37
CTSL P07711 1/20 0.37
ADRB1 P08588 5/20 0.37
ADRB3 P13945 2/20 0.36
THRB P10828 1/20 0.35
HTT P42858 1/20 0.35
KDM4E B2RXH2 1/20 0.34
HTR1A P08908 1/20 0.34
CHRM5 P08912 1/20 0.34
DRD2 P14416 1/20 0.34
ADRA2B P18089 1/20 0.34
DRD4 P21917 1/20 0.34
SLC6A2 P23975 1/20 0.34
FPR3 P25089 1/20 0.34
ADRA1D P25100 1/20 0.34
HTR1D P28221 1/20 0.34
HTR1B P28222 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7778742 0.88 CTSV (0.42) KIF11ADRB2NR1I2CTSVCTSL
SCHEMBL7781344 0.83 ADRB2 (0.40) KIF11ADRB2NR1I2CTSVCTSL
SCHEMBL6913351 0.83 ADRB2 (0.54) ADRB2NR1I2ADRB1ADRB3KDM4E
SCHEMBL7778756 0.83 CTSV (0.38) KIF11ADRB2CTSVCTSLADRB3
Hydrochloric Acid SCHEMBL7108122 0.82 ADRB2 (0.53) ADRB2NR1I2ADRB1ADRB3KDM4E
SCHEMBL7782053 0.79 CTSV (0.43) CTSVCTSLHTTDRD2DRD4
SCHEMBL7778926 0.78 KIF11 (0.41) KIF11ADRB2CTSVCTSLTHRB
SCHEMBL7779190 0.77 CTSV (0.45) CTSVCTSLHTR1AADRA1DADRA1A
SCHEMBL6916301 0.71 ADRB2 (0.46) ADRB2ADRB1ADRB3DRD2DRD4
SCHEMBL12886607 0.71 MAOA (0.57) KIF11NR1I2CTSVCTSLTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1128845-A1 COMBINATIONS COMPRISING A BETA-AGONIST AND A FURTHER ANTDIABETIC AGENT SMITHKLINE BEECHAM PLC (GB) 2001-09-05 EP disclosed
WO-2000027434-A1 COMBINATIONS COMPRISING A BETA-AGONIST AND A FURTHER ANTIDIABETIC AGENT SMITHKLINE BEECHAM P.L.C. (GB) 2000-05-18 WO disclosed